series-c-plus
Stage
1
Investors
About
Trinity Biotech develops, manufactures, and markets clinical diagnostic systems including reagents and instrumentation for point-of-care and laboratory testing, with products detecting infectious diseases, autoimmune disorders, hemoglobin disorders, and diabetic markers.
Explore Trinity Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.